System Transmission

Top Signal

100#1 JOB

Activity

2163Ripe

+917 today

System

Livenow

Terminal Asset View

stockNASDAQ

CSTL

$25.56+0.95%

Castle Biosciences Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

32Neutral

Live Analysis Active

Company Mission

Castle Biosciences creates specialized genetic tests that help doctors determine how aggressive a patient's skin cancer might be. Doctors use these tests to decide on the best treatment plan for their patients. The company makes money by selling these tests to hospitals, clinics, and healthcare providers.

CST

Industry Context

Castle Biosciences operates in the healthcare diagnostics industry, specifically focusing on genetic testing. This sector is growing as personalized medicine becomes more common, but it also faces challenges like changing insurance reimbursement policies and regulatory approvals for new tests.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

40Matrix

Market Momentum

26.8— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.5x— Normal Volume

Today's Change

0.95%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing CSTL across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 08:03 AM UTC

As-of 03-15-2026 07:48 UTC

Develops tests that help doctors predict cancer risks and treatment responses, selling these diagnostic tools to hospitals and clinics.

The stock's momentum indicator shows it dropped too fast recently, suggesting it might be due for a short-term bounce showing consolidation pattern.

Healthcare diagnostics sector faces regulatory uncertainty, which could impact companies developing new medical tests.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...